The current valuation score of Anixa Biosciences Inc is 8.08, ranking 161 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.32, which is -34.94% below the recent high of -5.41 and -90.56% above the recent low of -15.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.